88 related articles for article (PubMed ID: 31963697)
21. CTHRC1 and PD‑1/PD‑L1 expression predicts tumor recurrence in prostate cancer.
Zhou Q; Xiong W; Zhou X; Gao RS; Lin QF; Liu HY; Li JN; Tian XF
Mol Med Rep; 2019 Nov; 20(5):4244-4252. PubMed ID: 31545446
[TBL] [Abstract][Full Text] [Related]
22. Disialyl GD2 ganglioside suppresses ICAM-1-mediated invasiveness in human breast cancer MDA-MB231 cells.
Kwon KM; Chung TW; Kwak CH; Choi HJ; Kim KW; Ha SH; Cho SH; Lee YC; Ha KT; Lee MJ; Kim CH
Int J Biol Sci; 2017; 13(3):265-275. PubMed ID: 28367091
[TBL] [Abstract][Full Text] [Related]
23. MiR-221 Is Specifically Elevated in PC3 Cells and its Deletion Reduces Adhesion, Motility and Growth.
Dart DA; Koushyar S; Lanning BE; Jiang W
Anticancer Res; 2019 Oct; 39(10):5311-5327. PubMed ID: 31570425
[TBL] [Abstract][Full Text] [Related]
24. Myoepithelial mRNA expression profiling reveals a common tumor-suppressor phenotype.
Barsky SH
Exp Mol Pathol; 2003 Apr; 74(2):113-22. PubMed ID: 12710942
[TBL] [Abstract][Full Text] [Related]
25. NES1/KLK10 and hNIS gene therapy enhanced iodine-131 internal radiation in PC3 proliferation inhibition.
Hu J; Shen W; Qu Q; Fei X; Miao Y; Huang X; Liu J; Wu Y; Li B
Front Med; 2019 Dec; 13(6):646-657. PubMed ID: 31119602
[TBL] [Abstract][Full Text] [Related]
26. Reduction of TSG101 protein has a negative impact on tumor cell growth.
Zhu G; Gilchrist R; Borley N; Chng HW; Morgan M; Marshall JF; Camplejohn RS; Muir GH; Hart IR
Int J Cancer; 2004 Apr; 109(4):541-7. PubMed ID: 14991575
[TBL] [Abstract][Full Text] [Related]
27. Downregulation of human kallikrein 10 (KLK10/NES1) by CpG island hypermethylation in breast, ovarian and prostate cancers.
Sidiropoulos M; Pampalakis G; Sotiropoulou G; Katsaros D; Diamandis EP
Tumour Biol; 2005; 26(6):324-36. PubMed ID: 16254462
[TBL] [Abstract][Full Text] [Related]
28. Expression and targeting of the tight junction protein CLDN1 in CLDN1-negative human breast tumor cells.
Hoevel T; Macek R; Mundigl O; Swisshelm K; Kubbies M
J Cell Physiol; 2002 Apr; 191(1):60-8. PubMed ID: 11920682
[TBL] [Abstract][Full Text] [Related]
29. Increase of GKLF messenger RNA and protein expression during progression of breast cancer.
Foster KW; Frost AR; McKie-Bell P; Lin CY; Engler JA; Grizzle WE; Ruppert JM
Cancer Res; 2000 Nov; 60(22):6488-95. PubMed ID: 11103818
[TBL] [Abstract][Full Text] [Related]
30. The carbonic anhydrase I locus contains a c-Myb target promoter and modulates differentiation of murine erythroleukemia cells.
Chen J; Kremer CS; Bender TP
Oncogene; 2006 May; 25(19):2758-72. PubMed ID: 16407849
[TBL] [Abstract][Full Text] [Related]
31. Evaluation of CAIX and CAXII Expression in Breast Cancer at Varied O2 Levels: CAIX is the Superior Surrogate Imaging Biomarker of Tumor Hypoxia.
Tafreshi NK; Lloyd MC; Proemsey JB; Bui MM; Kim J; Gillies RJ; Morse DL
Mol Imaging Biol; 2016 Apr; 18(2):219-31. PubMed ID: 26276155
[TBL] [Abstract][Full Text] [Related]
32. Carbonic anhydrase III is a new target of HIF1α in prostate cancer model.
Okuyan D; Aydogan Turkoglu S; Kockar F
Gene; 2020 Dec; 762():145034. PubMed ID: 32777521
[TBL] [Abstract][Full Text] [Related]
33. Collagen and fibronectin promote an aggressive cancer phenotype in breast cancer cells but drive autonomous gene expression patterns.
Nolan J; Mahdi AF; Dunne CP; Kiely PA
Gene; 2020 Nov; 761():145024. PubMed ID: 32755659
[TBL] [Abstract][Full Text] [Related]
34. [Screening of phosphoprotein associated with glycosphingolipid microdomains 1 (PAG1) by cDNA microarray and influence of overexpression of PAG1 on biologic behavior of human metastatic prostatic cancer cell line in vitro].
Yu WJ; Wang YW; Xie ZG; You JF; Wang JL; Cui XL; Pei F; Zheng J
Zhonghua Bing Li Xue Za Zhi; 2010 Feb; 39(2):88-94. PubMed ID: 20388373
[TBL] [Abstract][Full Text] [Related]
35. Genetic manipulation of stromal cell-derived factor-1 attests the pivotal role of the autocrine SDF-1-CXCR4 pathway in the aggressiveness of breast cancer cells.
Kang H; Mansel RE; Jiang WG
Int J Oncol; 2005 May; 26(5):1429-34. PubMed ID: 15809737
[TBL] [Abstract][Full Text] [Related]
36. The biomarker features of miR-145-3p determined via meta-analysis validated by qRT-PCR in metastatic cancer cell lines.
Örs Kumoğlu G; Döşkaya M; Gulce Iz S
Gene; 2019 Aug; 710():341-353. PubMed ID: 31195093
[TBL] [Abstract][Full Text] [Related]
37. Insulin like growth factor binding protein-7 reduces growth of human breast cancer cells and xenografted tumors.
Amemiya Y; Yang W; Benatar T; Nofech-Mozes S; Yee A; Kahn H; Holloway C; Seth A
Breast Cancer Res Treat; 2011 Apr; 126(2):373-84. PubMed ID: 20464481
[TBL] [Abstract][Full Text] [Related]
38. Breast cancer cell behaviors on staged tumorigenesis-mimicking matrices derived from tumor cells at various malignant stages.
Hoshiba T; Tanaka M
Biochem Biophys Res Commun; 2013 Sep; 439(2):291-6. PubMed ID: 23978418
[TBL] [Abstract][Full Text] [Related]
39. ΔNp63α induces the expression of FAT2 and Slug to promote tumor invasion.
Dang TT; Westcott JM; Maine EA; Kanchwala M; Xing C; Pearson GW
Oncotarget; 2016 May; 7(19):28592-611. PubMed ID: 27081041
[TBL] [Abstract][Full Text] [Related]
40. Biologic role of activated leukocyte cell adhesion molecule overexpression in breast cancer cell lines and clinical tumor tissue.
Hein S; Müller V; Köhler N; Wikman H; Krenkel S; Streichert T; Schweizer M; Riethdorf S; Assmann V; Ihnen M; Beck K; Issa R; Jänicke F; Pantel K; Milde-Langosch K
Breast Cancer Res Treat; 2011 Sep; 129(2):347-60. PubMed ID: 20972617
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
